Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus.
<h4>Background</h4>Friedreich ataxia (FRDA) is caused by a homozygous GAA repeat expansion mutation within intron 1 of the FXN gene, which induces epigenetic changes and FXN gene silencing. Bisulfite sequencing studies have identified 5-methylcytosine (5 mC) DNA methylation as one of the...
Guardado en:
Autores principales: | Sahar Al-Mahdawi, Chiranjeevi Sandi, Ricardo Mouro Pinto, Mark A Pook |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b320c92f260140e9b5a5428ba4d0696d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation
por: Layne N. Rodden, et al.
Publicado: (2021) -
Friedreichs ataxia in a diabetic patient
por: Inna Igorevna Klefortova, et al.
Publicado: (2010) -
Current and emerging treatment options in the management of Friedreich ataxia
por: Michelangelo Mancuso, et al.
Publicado: (2010) -
Induced pluripotent stem cells-derived neurons from patients with Friedreich ataxia exhibit differential sensitivity to resveratrol and nicotinamide
por: Pauline Georges, et al.
Publicado: (2019) -
PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia.
por: Daniele Marmolino, et al.
Publicado: (2010)